Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia

Hemophilia A and B are bleeding disorders caused by a deficiency of clotting factor VIII and IX, respectively. Patients with severe hemophilia (< 0.01 IU mL(−1)) and some patients with moderate hemophilia (0.01–0.05 IU mL(−1)) administer clotting factor concentrates prophylactically. Desmopressin...

Descripción completa

Detalles Bibliográficos
Autores principales: Preijers, Tim, Schütte, Lisette M., Kruip, Marieke J. H. A., Cnossen, Marjon H., Leebeek, Frank W. G., van Hest, Reinier M., Mathôt, Ron A. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808974/
https://www.ncbi.nlm.nih.gov/pubmed/32936401
http://dx.doi.org/10.1007/s40262-020-00936-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808974/
https://www.ncbi.nlm.nih.gov/pubmed/32936401
http://dx.doi.org/10.1007/s40262-020-00936-5

Ejemplares similares